Since 2008 ASTRRA has been revolutionizing packaging automation. Based on industry standard wireless communications protocols, ASTRRA is a distributed control system which eliminates …

2022年6月17日 · 研究方法： ASTRRA是一项由研究者发起的、开放标签、前瞻性、随机、多中心、Ⅲ期试验。 研究主要评估了对于绝经前状态或化疗后卵巢功能恢复的激素受体阳性乳腺癌 …

ASTRRA是一项开放标签、前瞻性、随机、多中心研究者发起的 III期临床研究。 研究入组的≤45岁绝经前ER+乳腺癌患者， 与SOFT研究化疗组的入组人群基本相似：中位年龄（40岁）、淋巴 …

2023年8月22日 · In this study, we present the results from the post-trial follow-up of the ASTRRA trial, which assessed the disease-free survival (DFS) and overall survival (OS) to evaluate the …

2022年6月2日 · Background: Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain Premenopausal or Regain Vaginal …

Most Future Friendly. It is a full fledged automated change-over system that lends itself extremely well to conveyor railing adjustments as well as any other adjustment point, linear or rotary. It is …

ASTRRA’s oneTouch automatic changeover system can handle all your rail and machine changeover adjustments. Since 2008 ASTRRA has been revolutionizing packaging …

2023年10月16日 · ASTRRA是一项由研究者发起的、开放标签、前瞻性、随机、多中心、Ⅲ期试验，该研究从韩国35所医疗机构入组I～III期绝经前≤45岁、HR+且接受过根治性切除术和（新） …

2023年8月23日 · Purpose: To determine the updated long-term outcomes of the Addition of Ovarian Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer …

2016年5月19日 · Through the ASTRRA trial, we can determine optimal endocrine therapy based on real-time ovarian function status for each premenopausal breast cancer patient with …